Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutation

Lignende værker

• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  af: Suda, Kenichi, et al.
  Udgivet: (2021)
• Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity
  af: Marcar, Lynnette, et al.
  Udgivet: (2019)
• Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
  af: Wang, Jun, et al.
  Udgivet: (2016)
• EGFR mutation heterogeneity and mixed response to EGFR tyrosine kinase inhibitors of non small cell lung cancer: a clue to overcoming resistance
  af: Remon, Jordi, et al.
  Udgivet: (2013)
• EGFR and K-Ras Mutations and Resistance of Lung Cancer to IGF-1R Tyrosine Kinase Inhibitors
  af: Kim, Woo-Young, et al.
  Udgivet: (2012)